Status:
TERMINATED
Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)
Lead Sponsor:
Biotronik SE & Co. KG
Conditions:
Cardiac Pacing
Electric Countershock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with implantable cardioverter defibrillators (ICDs) should undergo regular device follow-ups every 3 months, to verify proper ICD function. However, many follow-ups are uneventful, revealing ...
Eligibility Criteria
Inclusion
- Indication for a single-chamber implantable cardioverter-defibrillator (ICD)
Exclusion
- Contraindication for ICD
- Indication for dual-chamber ICD or cardiac resynchronization therapy
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00858559
Start Date
March 1 2009
End Date
December 1 2011
Last Update
August 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology in Tangram House
Düsseldorf, Germany, 40237